Description

6-(1-Methyl-1,2,3,6-Tetrahydro-Pyridin-4-Yl)-1H-Indazole is a high-purity, advanced pharmaceutical intermediate characterized by its unique fused heterocyclic structure. This compound is of significant value for research and development in medicinal chemistry, serving as a critical building block for synthesizing novel therapeutic agents. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing new drug candidates, particularly in the areas of central nervous system (CNS) and oncology research.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel active pharmaceutical ingredients (APIs) targeting various disease pathways.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• CNS Drug Development: Employed in the research of potential therapeutics for neurological and psychiatric disorders due to its structural motifs.
• Oncology Research: Serves as a building block for developing potential kinase inhibitors and other targeted cancer therapies.
• Chemical Biology Probes: Utilized in the design and synthesis of molecular probes to study biological processes and identify new drug targets.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and process development services for the pharmaceutical industry.

Basic Information

Product Name	6-(1-Methyl-1,2,3,6-Tetrahydro-Pyridin-4-Yl)-1H-Indazole
CAS No.	885272-32-2
Molecular Formula	C13H15N3
Molecular Weight	213.28 g/mol
Synonyms	6-(1-Methyl-1,2,3,6-tetrahydro-4-pyridinyl)-1H-indazole; 1H-Indazole, 6-(1-methyl-1,2,3,6-tetrahydro-4-pyridinyl)-; 6-(1-Methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indazole; 6-(N-Methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indazole; 6-(1-Methyl-4-piperidinyl)-1H-indazole (tautomeric form); 885272-32-2; 6-(1-Methyl-1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indazole
EINECS	Contact for details

Quality Control

Our 6-(1-Methyl-1,2,3,6-Tetrahydro-Pyridin-4-Yl)-1H-Indazole is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, MS), to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing all specifications and test results is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms to reference spectrum
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Individual impurity ≤ 0.5% Total impurities ≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.